Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Adaptive Cardiac Resynchronization Therapy Optimization at Rest and During Exercise (AdOPT CRT)

19. juni 2019 opdateret af: Medtronic Cardiac Rhythm and Heart Failure
The AdOPT Cardiac Resynchronization Therapy (CRT) study is an acute, prospective, multi-center, non-randomized investigational study designed to compare indices of cardiac function at device settings optimized using the investigational Adaptive CRT (aCRT) algorithm versus nominal programming. The comparison will be performed during rest, atrial pacing and sub-maximal exercise. AdOPT CRT is a sub study of the Adaptive CRT Study (NTC00980057) being conducted in Europe.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Adaptive CRT is an implantable heart failure device feature that attempts to optimize CRT without echocardiographic testing.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

12

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Subject is age 18 or greater
  • Subject is willing to sign and date the study Informed Consent form
  • Subject has been implanted with a clinically indicated CRT-D device (Medtronic Vision 3D or Protecta models) for at least 1 month but less than 7 months from the date of study enrollment

Exclusion Criteria:

  • Subject has a history of persistent or permanent AF for which pharmacological therapy and/or cardioversion have been unsuccessful or have not been attempted.
  • Subject has atrial or ventricular tachyarrhythmias or frequent atrial or ventricular ectopy at the time of enrollment.
  • Subject's resting heart rate at the time of enrollment exceeds 90 bpm.
  • Subject had CRT system implanted for more than 7 months from the date of the study enrollment
  • Subject has complete AV block.
  • Subject had previous mechanical valve surgeries.
  • Subject has congenital heart disease.
  • Subject has contraindication for an exercise test.
  • Subject is unable to perform a sub-maximal exercise test.
  • It is not possible to acquire technically acceptable echocardiographic images.
  • Subject has medical conditions that would limit study participation.
  • Subject is pregnant (all women of child-bearing potential must undergo a pregnancy test within seven days prior to the study visit).
  • Subject is enrolled in the Adaptive CRT study
  • Subject is enrolled in concurrent studies which could confound the results of this study.
  • Subject meets exclusion criteria required by local law

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: CRT pacing at rest and during exercise
Rest and sub-maximal exercise
CRT pacing with aCRT settings and BiV pacing with nominal programming at rest and during submaximal exercise

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Stroke Volume at Rest
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in stroke volume (SV) between BiV pacing with aCRT settings and BiV pacing with nominal settings at rest. Biventricular pacing is a type of pacing that paces both the right and left ventricles of the heart. Stroke volume is the volume of blood pumped from a ventricle in one heart beat.
Test day visit (within 14 days of enrollment)
Stroke Volume During Atrial Pacing.
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in SV between BiV pacing with aCRT settings and BiV pacing with nominal settings during atrial pacing. Atrial pacing occurs at 20 beats-per-minute (bpm) above the subject's resting heart rate.
Test day visit (within 14 days of enrollment)
Stroke Volume During Sub-maximal Exercise.
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in SV between BiV pacing with aCRT settings and BiV pacing with nominal settings during sub-maximal exercise. Sub-maximal exercise is exercise performed at a level below maximum effort. The subject will perform sub-maximal exercise to achieve target heart rate close to 75% of the age-predicted maximal heart rate.
Test day visit (within 14 days of enrollment)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Cardiac Function With aCRT Settings at Rest
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in blood pressure (BP)-derived and echocardiogram (echo)-derived parameters of cardiac function between BiV pacing with aCRT settings and BiV pacing with nominal settings at rest.
Test day visit (within 14 days of enrollment)
Cardiac Function With Nominal Settings at Rest.
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in BP-derived and echo-derived parameters of cardiac function between BiV pacing with nominal settings and intrinsic conduction at rest.
Test day visit (within 14 days of enrollment)
Cardiac Function With aCRT Settings During Sub-maximal Exercise.
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in BP-derived and echocardiogram (echo)-derived parameters of cardiac function between BiV pacing with aCRT settings and BiV pacing with nominal settings during sub-maximal exercise.
Test day visit (within 14 days of enrollment)
Cardiac Function With Nominal Settings During Sub-maximal Exercise.
Tidsramme: Test day visit (within 14 days of enrollment)
Difference in BP-derived and echo-derived parameters of cardiac function between BiV pacing with nominal settings and intrinsic conduction during sub-maximal exercise.
Test day visit (within 14 days of enrollment)
Electrical Conduction at Rest.
Tidsramme: Test day visit (within 14 days of enrollment)
Electrical conduction will be evaluated at rest by measuring the subject's intrinsic atrio-ventricular (AV) interval. The AV interval is the amount time between the start of atrial contraction and the start of ventricular contraction.
Test day visit (within 14 days of enrollment)
Electrical Conduction During Sub-maximal Exercise.
Tidsramme: Time Frame: Test day visit (within 14 days of enrollment)
Electrical conduction will be evaluated during sub-maximal exercise by measuring the subject's intrinsic AV interval.
Time Frame: Test day visit (within 14 days of enrollment)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studiestol: AdOPT CRT/aCRT Study Team, Medtronic

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. november 2011

Primær færdiggørelse (Faktiske)

1. marts 2012

Studieafslutning (Faktiske)

1. marts 2012

Datoer for studieregistrering

Først indsendt

16. november 2011

Først indsendt, der opfyldte QC-kriterier

18. november 2011

Først opslået (Skøn)

21. november 2011

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. august 2019

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

19. juni 2019

Sidst verificeret

1. juni 2019

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • AdOPT CRT Sub Study

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Hjertefejl

Abonner